An update on COVID-19 in paediatric and young adults with nephrotic syndrome, receiving chronic immunosuppression during the Omicron pandemic

J Nephrol. 2022 Jul;35(6):1775-1776. doi: 10.1007/s40620-022-01319-8. Epub 2022 Apr 9.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • COVID-19*
  • Child
  • Graft vs Host Disease*
  • Humans
  • Immunosuppression Therapy
  • Immunosuppressive Agents / adverse effects
  • Nephrotic Syndrome* / diagnosis
  • Nephrotic Syndrome* / drug therapy
  • Pandemics
  • Young Adult

Substances

  • Immunosuppressive Agents